Zogenix lands $60M in first round
|
VENTURE CAPITAL |
|||
|
COMPANY |
AMOUNT/ROUND |
LEAD INVESTORS |
DESCRIPTION |
|
Zogenix
|
$60M
|
Clarus Ventures and Domain Associates |
The company's initial focus is the completion of the late-stage development and commercialization of Intraject sumatriptan. |
|
Codexis
|
$37M
|
Bio*One Capital |
Much of the money will go to financing a new research and development arm in Singapore that will support its work in generics. |
|
Medior
|
$7M
|
Polaris Ventures and Morgenthaler Ventures |
Medior is developing therapeutics for the treatment of fibrotic disorders and diseases. |